Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56251 - 56275 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	IGFBP7	3490	upregulated	panobinostat results in increased expression of IGFBP7 mRNA	4q12	A21037
Panobinostat	Approved Investigational	IL17RD	54756	downregulated	panobinostat results in decreased expression of IL17RD mRNA	3p14.3	A21037
Panobinostat	Approved Investigational	IL1RAPL1	11141	downregulated	panobinostat results in decreased expression of IL1RAPL1 mRNA	Xp21.3-p21.2	A21037
Panobinostat	Approved Investigational	IL20RB	53833	upregulated	panobinostat results in increased expression of IL20RB mRNA	3q22.3	A21037
Panobinostat	Approved Investigational	IL27RA	9466	upregulated	panobinostat results in increased expression of IL27RA mRNA	19p13.12	A21037
Panobinostat	Approved Investigational	INF2	64423	upregulated	panobinostat results in increased expression of INF2 mRNA	14q32.33	A21037
Panobinostat	Approved Investigational	INHBE	83729	upregulated	panobinostat results in increased expression of INHBE mRNA	12q13.3	A21037
Panobinostat	Approved Investigational	INSC	387755	upregulated	panobinostat results in increased expression of INSC mRNA	11p15.2	A21037
Panobinostat	Approved Investigational	IQCA1	79781	upregulated	panobinostat results in increased expression of IQCA1 mRNA	2q37.2-q37.3	A21037
Panobinostat	Approved Investigational	IQGAP1	8826	upregulated	panobinostat results in increased expression of IQGAP1 mRNA	15q26.1	A21037
Panobinostat	Approved Investigational	IRF6	3664	upregulated	panobinostat results in increased expression of IRF6 mRNA	1q32.2	A21037
Panobinostat	Approved Investigational	IRX1	79192	upregulated	panobinostat results in increased expression of IRX1 mRNA	5p15.33	A21037
Panobinostat	Approved Investigational	IRX2	153572	upregulated	panobinostat results in increased expression of IRX2 mRNA	5p15.33	A21037
Panobinostat	Approved Investigational	IRX3	79191	upregulated	panobinostat results in increased expression of IRX3 mRNA	16q12.2	A21037
Panobinostat	Approved Investigational	ITGA8	8516	upregulated	panobinostat results in increased expression of ITGA8 mRNA	10p13	A21037
Panobinostat	Approved Investigational	ITGA9	3680	upregulated	panobinostat results in increased expression of ITGA9 mRNA	3p22.2	A21037
Panobinostat	Approved Investigational	ITGB5	3693	downregulated	panobinostat results in decreased expression of ITGB5 mRNA	3q21.2	A21037
Panobinostat	Approved Investigational	ITIH5	80760	upregulated	panobinostat results in increased expression of ITIH5 mRNA	10p14	A21037
Panobinostat	Approved Investigational	ITPR2	3709	upregulated	panobinostat results in increased expression of ITPR2 mRNA	12p11.23	A21037
Panobinostat	Approved Investigational	JADE2	23338	upregulated	panobinostat results in increased expression of JADE2 mRNA	5q31.1	A21037
Panobinostat	Approved Investigational	JAZF1	221895	upregulated	panobinostat results in increased expression of JAZF1 mRNA	7p15.2-p15.1	A21037
Panobinostat	Approved Investigational	JDP2	122953	upregulated	panobinostat results in increased expression of JDP2 mRNA	14q24.3	A21037
Panobinostat	Approved Investigational	JUN	3725	upregulated	panobinostat results in increased expression of JUN mRNA	1p32.1	A21037
Panobinostat	Approved Investigational	KANK4	163782	upregulated	panobinostat results in increased expression of KANK4 mRNA	1p31.3	A21037
Panobinostat	Approved Investigational	KAT2B	8850	downregulated	panobinostat results in decreased expression of KAT2B mRNA	3p24.3	A21037

Displaying entries 56251 - 56275 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability